Advertisement
The leading life science news channel in the Nordic region.
Collaboration - April 5, 2022
Karolinska Institutet (KI) and Karolinska University Hospital have strengthened collaboration within precision medicine by establishing the Precision Medicine Centre Karolinska (PMCK) and have now entered into a cooperation agreement. Developing a cooperation agreement between KI and the hospital has been one step in working to overcome the boundaries between academia and the healthcare services, states […]
Collaboration - April 5, 2022
Rebel and Oslo Cancer Cluster Incubator have started a collaboration to tighten the ties between cancer research and information technology. Rebel connects information technology- and software developers in the centre of Oslo. Since the hub opened last autumn, they have experienced that the need for technological competencies in Oslo is massive, also in the health […]
Acquisition - April 4, 2022
AddLife acquires Irish company O’Flynn Medical and German company BioCat. O’Flynn Medical is an independent distributor offering product sales, rental and technical services to the hospital sector, private customers and nursing homes in Ireland. The company will become part of the Healthcare 21 Group, which AddLife acquired to the business area Medtech in 2021. O’Flynn […]
New Market - April 4, 2022
Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved a 2.0 mg dose of Ozempic (once-weekly semaglutide subcutaneous injection), a glucagon-like peptide-1 (GLP-1) analogue for the treatment of adults with type 2 diabetes. Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the […]
New Market - April 1, 2022
InDex Pharmaceuticals Holding is planning for self-commercialization of the drug candidate cobitolimod in the US with strategic collaborations in other regions. Launch is expected in 2027, with the potential for annual sales to reach more than USD 1 billion, in moderate to severe left-sided ulcerative colitis, states the company. Read more: Hey there Peter Zerhouni, […]
Pharma article - April 1, 2022
The controversial trachea transplantations by the notorious surgeon Paolo Macchiarini created a storm in the scientific world. It initiated a debate on the intersection between research and healthcare and the importance of a distinct ethical compass for the patient’s safety. At first the world was in awe about the groundbreaking news. Paolo Macchiarini, a well-renowned […]
Uncategorized - March 31, 2022
Between 2009 and 2019, the number of life science companies in the Stockholm-Uppsala region increased by almost 50%. This is stated in a report published by the Stockholm Science City Foundation on the 31 of March. Half of the employees within Sweden’s life science work in the region, which means 31,500 people at nearly 1,000 […]
Clinical Trials - March 31, 2022
TILT Biotherapeutics has announced positive interim progress and safety data from its phase 1 clinical trials in metastatic melanoma (T215 – the ‘TUNINTIL’ trial) and solid tumors (T115 – the ‘TUNIMO’ trial). These two trials, with patients in Denmark, France, and Finland, are of the company’s oncolytic immunotherapy asset TILT-123, designed to stimulate T-cells to […]
Profiles in Science - March 30, 2022
Ardem Patapoutian searched for answers to a fundamental question, which led to complex discoveries and a whole new exciting field. Ardem Patapoutian shared the Nobel Prize in Physiology or Medicine 2021 with David Julius for their discoveries of receptors for temperature and touch. These discoveries have led to a better understanding of how the nervous […]
COVID-19 - March 30, 2022
KeyPlants has shipped a first-of-its-kind vaccine manufacturing filling facility to Senegal in West Africa. After the facility is installed and becomes fully operational later in 2022, it will be the only regional manufacturing hub on the continent outside of South Africa capable of producing finished COVID-19 and other life-saving vaccines, states KeyPlants. “We are proud […]
This site uses cookies